The MOH released the results of its survey on Feb. 10. More than 4,000 individuals were invited to participate, with 2,049 completing the interview process. The respondents were interviewed between 21 and 30 days after they received their COVID-19 booster doses.
The survey identified several categories of vaccine reactions for both men and women. It also scrutinized a subset of female respondents regarding their menstrual cycle before and after getting boosted.
According to the MOH poll, six different categories of pre-existing diseases became worse following injection with the COVID-19 vaccine booster. Heart disease worsened in 5.4 percent of respondents, hypertension exacerbated in 6.3 percent of respondents and seven percent of survey participants claimed the booster aggravated their lung disease.
Furthermore, 9.3 percent of respondents said their diabetes was exacerbated following the booster dose. Depression and anxiety disorder became worse post-booster in 26.4 percent of survey participants, while 24.2 percent of respondents who had autoimmune disease said the COVID-19 vaccine booster exacerbated it. (Related: Israel now has more covid infections per capita than any country in the world, even as "booster shots" are being widely administered there.)
About five percent of respondents reported a neurological adverse event. Almost four percent of respondents reported an allergic reaction after the booster. Aside from these, the MOH poll also found general post-vaccination reactions and local reactions at the injection site.
Fifty-nine out of 615 female respondents under 54 years old – 9.6 percent – said they experienced menstrual irregularities after the booster. Prior to getting the COVID-19 vaccine booster, more than 88 percent of women in this sub-group had a regular menstrual cycle. But after getting boosted, 31.1 percent sought medical treatment for their irregular menstrual cycles.
The release of the MOH's poll followed its decision to approve subsequent COVID-19 vaccine doses.
According to the Times of Israel, the Jewish nation began its COVID-19 booster campaign at the beginning of August 2021. The third dose was initially made available to Israelis aged 60 and older. It was later expanded to include anyone 30 years old and up. The initial decision to approve a third shot came amid the spread of the B16172 delta variant first identified in India.
Israeli Prime Minister Naftali Bennett exhorted citizens to get boosted, saying "this is a privilege that no other country has." Health Minister Nitzan Horowitz agreed with the prime minister, saying in a press conference: "We must continue vaccinating at a fast pace. It is critical for success."
MOH Director-General Nachman Ash later announced that health officials approved the fourth COVID-19 vaccine dose in December 2021. The move to approve a fourth shot came amid the spread of the B11529 omicron variant first identified in South Africa. While more infectious than the earlier delta strain, omicron causes milder symptoms in infected individuals.
According to Ash, those with weakened immune systems would be the first ones to get injected with the fourth vaccine dose. He remarked that the MOH would observe the data before deciding to approve a fourth dose for the general population. "We will continue to track the data on a daily basis, and we will see if we need to broaden this recommendation to more of the population," said Ash.
Watch below the video of Israeli Prime Minister Naftali Bennett urging people to get boosted.
This video is from the Iynikas World channel on Brighteon.com.
VaccineInjuryNews.com has more about the injuries caused by COVID-19 vaccine boosters.